Together, these findings suggest that CB2R could promote steatosis directly by inducing liver inflammation, contributing to NASH, and indirectly by increasing the hepatic CB1R expression, thereby contributing to NAFLD, NASH, and liver fibrosis. The gene discussed is CNR1; the disease is Hepatic fibrosis.